VNDA starts phase-3 trial for resetting circadian clock: http://finance.yahoo.com/news/Vanda-Pharmaceuticals-prnews-3548832254.html?x=0&.v=1 The main patient pool is expected to be the blind, but this is a drug I might consider taking if the data pan out.